Klee Ann R. 4
4 · Sotera Health Co · Filed Mar 6, 2024
Insider Transaction Report
Form 4
Klee Ann R.
Director
Transactions
- Sale
Common Stock, $0.01 par value per share ("Common Stock")
2024-03-04$14.31/sh−5,750$82,268→ 86,735 total
Footnotes (3)
- [F1]On March 4, 2024, the Reporting Person sold a total of 5,750 shares of Common Stock of the Issuer in an underwritten public secondary offering (the "Offering").
- [F2]Reflects a price equal to the Offering price per share less underwriting discounts and commissions payable thereon, as disclosed in the Issuer's Prospectus 424(b)(7), filed with the United States Securities and Exchange Commission on February 29, 2024.
- [F3]Consists of 15,712 Restricted Stock Units and 71,023 shares of Common Stock, including 62,537 shares of vested Common Stock and 8,486 shares of unvested Common Stock. The unvested shares of Common Stock will vest on a daily basis pro rata through May 27, 2025.